µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
ºÐ·ù¾øÀ½
 
´Ü¹éÁú ÀλêÈ­È¿¼Ò ¾ïÁ¦Á¦(Protein kinase inhibitors)

´ÜÀÏÁ¦ ÃÑ 108°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
axitinib 5mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
cabozantinib (s)-malate 76.03mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
cabozantinib (s)-malate 50.69mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
cabozantinib (s)-malate 25.34mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
brigatinib 30mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
brigatinib 90mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
brigatinib 180mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
Midostaurin 25mg¿¬Áúĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
abemaciclib 50mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
abemaciclib 100mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
abemaciclib 150mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
gilteritinib fumarate 44.2mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
larotrectinib sulfate 30.7mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
larotrectinib sulfate 122.9mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
larotrectinib sulfate 2.46g¾×ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
ribociclib succinate 254.4mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
nilotinib hydrochloride monohydrate 55.150 mgĸ½¶ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
dacomitinib hydrate 15.576mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
dacomitinib hydrate 31.153mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
dacomitinib hydrate 46.729mgÁ¤ÇØ´çÁ¦Ç° ¸®½ºÆ®·Î
[4]
º¹ÇÕÁ¦ ÃÑ0°³
¼ººÐ¸í Á¦Çü ÇØ´çÁ¦Ç°¸®½ºÆ®
°Ë»ö°á°ú°¡ ¾ø½À´Ï´Ù.
 
ºñÆ®µå·¯±×ÀÎÆ÷